Cargando…
A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant
Episodic ataxia 2 (EA2) is an autosomal dominant disorder caused by mutations in the gene CACNA1A that encodes the pore-forming Ca(V)2.1 calcium channel subunit. The majority of EA2 mutations reported so far are nonsense or deletion/insertion mutations predicted to form truncated proteins. Heterolog...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940211/ https://www.ncbi.nlm.nih.gov/pubmed/27260834 http://dx.doi.org/10.1016/j.nbd.2016.05.020 |
_version_ | 1782442115839557632 |
---|---|
author | Dahimene, Shehrazade Page, Karen M. Nieto-Rostro, Manuela Pratt, Wendy S. D'Arco, Marianna Dolphin, Annette C. |
author_facet | Dahimene, Shehrazade Page, Karen M. Nieto-Rostro, Manuela Pratt, Wendy S. D'Arco, Marianna Dolphin, Annette C. |
author_sort | Dahimene, Shehrazade |
collection | PubMed |
description | Episodic ataxia 2 (EA2) is an autosomal dominant disorder caused by mutations in the gene CACNA1A that encodes the pore-forming Ca(V)2.1 calcium channel subunit. The majority of EA2 mutations reported so far are nonsense or deletion/insertion mutations predicted to form truncated proteins. Heterologous expression of wild-type Ca(V)2.1, together with truncated constructs that mimic EA2 mutants, significantly suppressed wild-type calcium channel function, indicating that the truncated protein produces a dominant-negative effect (Jouvenceau et al., 2001; Page et al., 2004). A similar finding has been shown for Ca(V)2.2 (Raghib et al., 2001). We show here that a highly conserved sequence in the cytoplasmic N-terminus is involved in this process, for both Ca(V)2.1 and Ca(V)2.2 channels. Additionally, we were able to interfere with the suppressive effect of an EA2 construct by mutating key N-terminal residues within it. We postulate that the N-terminus of the truncated channel plays an essential part in its interaction with the full-length Ca(V)2.1, which prevents the correct folding of the wild-type channel. In agreement with this, we were able to disrupt the interaction between EA2 and the full length channel by co-expressing a free N-terminal peptide. |
format | Online Article Text |
id | pubmed-4940211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Academic Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-49402112016-09-01 A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant Dahimene, Shehrazade Page, Karen M. Nieto-Rostro, Manuela Pratt, Wendy S. D'Arco, Marianna Dolphin, Annette C. Neurobiol Dis Article Episodic ataxia 2 (EA2) is an autosomal dominant disorder caused by mutations in the gene CACNA1A that encodes the pore-forming Ca(V)2.1 calcium channel subunit. The majority of EA2 mutations reported so far are nonsense or deletion/insertion mutations predicted to form truncated proteins. Heterologous expression of wild-type Ca(V)2.1, together with truncated constructs that mimic EA2 mutants, significantly suppressed wild-type calcium channel function, indicating that the truncated protein produces a dominant-negative effect (Jouvenceau et al., 2001; Page et al., 2004). A similar finding has been shown for Ca(V)2.2 (Raghib et al., 2001). We show here that a highly conserved sequence in the cytoplasmic N-terminus is involved in this process, for both Ca(V)2.1 and Ca(V)2.2 channels. Additionally, we were able to interfere with the suppressive effect of an EA2 construct by mutating key N-terminal residues within it. We postulate that the N-terminus of the truncated channel plays an essential part in its interaction with the full-length Ca(V)2.1, which prevents the correct folding of the wild-type channel. In agreement with this, we were able to disrupt the interaction between EA2 and the full length channel by co-expressing a free N-terminal peptide. Academic Press 2016-09 /pmc/articles/PMC4940211/ /pubmed/27260834 http://dx.doi.org/10.1016/j.nbd.2016.05.020 Text en © 2016 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dahimene, Shehrazade Page, Karen M. Nieto-Rostro, Manuela Pratt, Wendy S. D'Arco, Marianna Dolphin, Annette C. A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant |
title | A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant |
title_full | A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant |
title_fullStr | A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant |
title_full_unstemmed | A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant |
title_short | A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant |
title_sort | ca(v)2.1 n-terminal fragment relieves the dominant-negative inhibition by an episodic ataxia 2 mutant |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940211/ https://www.ncbi.nlm.nih.gov/pubmed/27260834 http://dx.doi.org/10.1016/j.nbd.2016.05.020 |
work_keys_str_mv | AT dahimeneshehrazade acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT pagekarenm acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT nietorostromanuela acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT prattwendys acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT darcomarianna acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT dolphinannettec acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT dahimeneshehrazade cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT pagekarenm cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT nietorostromanuela cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT prattwendys cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT darcomarianna cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant AT dolphinannettec cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant |